Michael E. Faerm
CIK 1647141 · Chief Financial Officer · last filed 2026-03-13
Michael E. Faerm is a Chief Financial Officer who has filed 11 SEC Form 4 insider transactions across 3 companies since 2015. Current disclosed insider exposure totals $6.4M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$6.35M
3
11
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Viracta Therapeutics, Inc. (VIRX) Delisted | Chief Financial Officer | — | $0.01 | — | $0 | 1 | 2024-05-16 |
| INVA | Sr VP & Chief Business Officer | 279,422 | $22.74 | $6.35M | $0 | 8 | 2017-11-22 |
| Innoviva, Inc. (THRX) Delisted | Sr VP & Chief Business Officer | 105,288 | $4.06 | $427.5K | $0 | 1 | 2015-07-27 |
Recent Filings
11 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-13 | — | Grant (A) | — | $0 | |
| 2024-05-16 | Viracta Therapeutics, Inc. (VIRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-11-22 | INVA | Tax (F) | −4,470 | -$58.9K | EDGAR |
| 2017-08-22 | INVA | Tax (F) | −3,179 | -$39.0K | EDGAR |
| 2017-05-23 | INVA | Tax (F) | −3,176 | -$37.7K | EDGAR |
| 2017-02-22 | INVA | Tax (F) | −5,860 | -$70.6K | EDGAR |
| 2017-01-19 | INVA | Grant (A) | +133,398 | $0 | EDGAR |
| 2016-11-22 | INVA | Tax (F) | −2,893 | -$31.6K | EDGAR |
| 2016-08-23 | INVA | Tax (F) | −9,544 | -$112.5K | EDGAR |
| 2016-01-19 | INVA | Grant (A) | +67,126 | $0 | EDGAR |